10-Q: CNO Financial Q3 Operating Income Rises, Strategic Shift to Core Insurance

CNO Financial Group reported increased net operating income for Q3 2025, alongside a significant goodwill impairment and a strategic decision to exit its fee services business to sharpen focus on core insurance operations.

Summary

• Net operating income increased to $127.2 million for Q3 2025, up from $119.2 million in Q3 2024.
• Net operating income for the first nine months of 2025 was $295.8 million, compared to $291.3 million in the same period of 2024.
• Reported net income for Q3 2025 was $23.1 million ($0.24 diluted EPS), compared to $9.3 million ($0.09 diluted EPS) in Q3 2024.
• Reported net income for the first nine months of 2025 was $136.4 million ($1.36 diluted EPS), down from $237.9 million ($2.18 diluted EPS) in the same period of 2024.
• A goodwill and other asset impairment charge of $96.7 million was recognized in Q3 2025, primarily related to the Optavise fee income segment.
• The company announced its intention to exit the fee services business within its Worksite Division, expecting to reduce annual fee revenue by approximately $30 million and increase annual pre-tax income by approximately $20 million.
• Operating return on equity (ROE) improved to 11.2% as of September 30, 2025, from 10.4% as of September 30, 2024.
• A second reinsurance transaction with CNO Bermuda Re, Ltd. was executed, reinsuring $1.8 billion of inforce supplemental health statutory reserves and 50% of new supplemental health business.
• The company repurchased 6.7 million shares of common stock for $259.9 million during the first nine months of 2025, with $480.4 million remaining repurchase authority.
• The quarterly common stock dividend was increased to $0.17 per share from $0.16 per share in May 2025.
• Total revenues for Q3 2025 increased to $1,188.7 million from $1,129.6 million in Q3 2024.
• Total revenues for the first nine months of 2025 were $3,344.3 million, slightly down from $3,352.3 million in the same period of 2024.
• The debt to total capital ratio (excluding AOCI) improved to 26.4% at September 30, 2025, from 32.1% at December 31, 2024.
• Holding company unrestricted cash and cash equivalents were $193.7 million, exceeding the minimum target of $150 million.

Sentiment

Score: 5

Explanation: While operating income and ROE showed improvement, the significant goodwill impairment and the overall decline in reported net income for the nine-month period weigh heavily. The strategic exit of a loss-making business and increased cash flow guidance are positive, but the immediate financial impact of the impairment and the ongoing legal proceedings introduce uncertainty. The outlook is cautiously optimistic, but the current period's reported results are mixed.

Positives

• Net operating income increased to $127.2 million in Q3 2025 from $119.2 million in Q3 2024.
• Operating ROE improved to 11.2% as of September 30, 2025, from 10.4% as of September 30, 2024, on target with guidance.
• Strategic exit of fee services business is expected to increase annual pre-tax income by approximately $20 million.
• Debt to total capital ratio (excluding AOCI) improved to 26.4% from 32.1%, indicating stronger financial leverage.
• Holding company liquidity of $193.7 million exceeds the minimum target of $150 million.
• Quarterly common stock dividend increased to $0.17 per share from $0.16 per share.
• Comprehensive annual actuarial review in Q3 2025 resulted in a net favorable impact of $21.0 million to net income and $41.3 million to pre-tax operating income.
• Investment income allocated to products increased by $16.9 million in Q3 2025 and $49.0 million in the first nine months of 2025 due to business growth and higher yields (over 6% new money rates for 11 quarters).
• Long-term care margin increased due to growth from short-duration products and retaining 100% of new business.

Negatives

• Net income for the first nine months of 2025 decreased significantly to $136.4 million from $237.9 million in the same period of 2024, primarily due to a $96.7 million goodwill and other asset impairment charge.
• Diluted EPS for the first nine months of 2025 decreased to $1.36 from $2.18 in the same period of 2024.
• The fee income segment reported net losses of $3.9 million for both Q3 and the first nine months of 2025, compared to a $9.4 million profit in the first nine months of 2024.
• The goodwill and other asset impairment charge of $96.7 million reflects lower than anticipated revenue and a decline in value of comparable publicly traded companies for the Optavise segment.
• Net non-operating income (loss) before taxes was a loss of $197.7 million for the first nine months of 2025, significantly worse than the $69.1 million loss in the same period of 2024.
• Changes in fair value of embedded derivative liabilities and market risk benefits resulted in a $62.5 million decrease in pre-tax earnings for the first nine months of 2025.
• Medicare supplement margin decreased in 2025 periods primarily due to modestly unfavorable claims.

Risks

• General economic, market, and political conditions, including inflation, market volatility, tariffs, and changes in tax laws, may affect investment values and ability to raise capital.
• Exposure to interest rate risk and volatility may negatively impact results.
• Future investment results, including realized losses and other-than-temporary impairment charges, may diminish asset value and impact profitability.
• The ultimate outcome of lawsuits and other legal/regulatory proceedings, including class actions, could have a material adverse effect.
• Ability to make anticipated changes to non-guaranteed elements of life insurance products.
• Ability to obtain adequate and timely rate increases on health products, including long-term care.
• Recoverability of deferred tax assets and the effect of potential ownership changes (Section 382) and tax rate changes on their value.
• Assumptions on tax return filings may be challenged by the IRS.
• Changes in accounting principles and their interpretation.
• Ability to satisfy financial ratio and balance requirements and other covenants of debt agreements.
• Ability to compete effectively against competitors with greater market share, higher ratings, financial resources, and brand recognition.
• Ability to generate sufficient liquidity to meet debt service obligations and other cash needs.
• Changes in capital deployment opportunities.
• Ability to maintain effective controls over financial reporting and modeling.
• Ability to recruit and retain productive agents and distribution partners.
• Customer response to new products, distribution channels, and marketing initiatives.
• Inflation or other unfavorable economic conditions may impact the sales and persistency of insurance products, a portion of insurance policy benefits affected by increased medical coverage costs, and various selling, general, and administrative expenses.
• Ability to maintain the financial strength ratings of CNO and its insurance company subsidiaries as well as the impact of ratings on business, ability to access capital, and the cost of capital.
• Regulatory changes or actions, now or in the future, including those relating to regulation of the financial affairs of insurance companies, such as the calculation of risk-based capital and minimum capital requirements, and payment of dividends and surplus debenture interest; regulation of the sale, underwriting, and pricing of products; health care regulation affecting health insurance products; and privacy laws and regulations.
• Changes in the Federal income tax laws and regulations which may affect or eliminate the relative tax advantages of some products or affect the value of deferred tax assets.
• Availability and effectiveness of reinsurance arrangements, as well as the impact of any defaults or failure of reinsurers to perform.
• The use or anticipated use of artificial intelligence ("AI") technologies, including generative AI, by the company or third-parties.
• The performance of third-party service providers (both domestic and international) and potential difficulties arising from outsourcing arrangements.
• Interruption in telecommunication, information technology, or other operational systems or failure to maintain the security, confidentiality, or privacy of sensitive data on such systems.
• Events of terrorism, natural disasters, or other catastrophic events, including potential adverse impacts from climate change which may increase the frequency or severity of weather-related disasters.
• Cyber-security attacks, risk of data loss, and other security breaches.
• Ineffectiveness of risk management policies and procedures in identifying, monitoring, and managing risks.

Future Outlook

CNO Financial Group narrowed its expected operating earnings per diluted share for 2025 to between $3.75 and $3.85, excluding significant items. The company anticipates a $2 million decrease in Q4 2025 fee income due to a shift towards Medicare supplement products. The effective tax rate on operating earnings is expected to be between 22.0% and 22.5%. The operating ROE target is increased to 200 basis points total improvement through 2027 from a 10% run rate in 2024, with a 50 basis point improvement expected in 2025. The expense ratio is projected to be approximately 19.0%. Expected excess cash flow to the holding company is increased to a range of $365 million to $385 million, reflecting the impact of the second Bermuda reinsurance transaction. The TechMod initiative is expected to cost $25 million in 2025, with most costs excluded from operating earnings.

Management Comments

• We focus on serving middle-income pre-retiree and retired Americans, which we believe are attractive, underserved, high growth markets.
• Management believes insurance product margin and income from insurance products help provide an additional understanding of the business and a more meaningful analysis of the results of our insurance product lines.
• Our primary investment focus is on investment income to support our liabilities for insurance products as opposed to the generation of investment gains (losses), and a long-term focus is necessary to maintain profitability over the life of the business.
• We are disciplined with our marketing expenditures and will increase or decrease our marketing spend depending on the current economics of the purchase or other factors.
• We believe that the 375 percent RBC ratio target continues to adequately support our financial strength and credit ratings.
• We believe that the existing cash available to the holding company, the cash flows to be generated from operations and other transactions will be sufficient to allow us to meet our debt service obligations, pay corporate expenses and satisfy other financial obligations.

Industry Context

The insurance industry continues to navigate a dynamic environment with rising interest rates impacting investment yields positively, as seen in CNO's sustained new money rates over 6%. However, the sector also faces ongoing regulatory scrutiny, as evidenced by NAIC's new guidelines on negative IMR and PBR for non-variable annuities, which could introduce capital volatility. The strategic shift by CNO to exit non-core fee services and focus on insurance, coupled with reinsurance transactions, reflects a broader industry trend towards optimizing capital and streamlining operations in response to market pressures and evolving customer preferences, particularly in the Medicare segment where CNO is shifting towards Medicare supplement products.

Comparison to Industry Standards

• CNO's operating ROE of 11.2% as of September 30, 2025, is on target with its guidance of a 50 basis point improvement from its 2024 run rate of 10%, indicating competitive performance within its segment.
• The consolidated statutory RBC ratio of 380% at September 30, 2025, exceeds the company's target of 375% and the minimum 350% reflected in its risk appetite statement, suggesting a strong capital position relative to industry benchmarks for U.S. based insurance subsidiaries.
• The company's financial strength ratings of "A" (Fitch, AM Best), "A-" (S&P), and "A3" (Moody's) for its primary insurance subsidiaries indicate a strong capacity to meet policyholder obligations, generally aligning with or slightly above the average for well-established regional or specialized insurers.
• The debt to total capital ratio (excluding AOCI) of 26.4% at September 30, 2025, is within the target range of 25% to 28%, demonstrating prudent leverage management compared to industry peers.

Corporate Governance

Legal Proceedings

• Platinum Partners Value Arbitrage Fund L.P. (in Official Liquidation) et al. v. CNO Financial Group, Inc. et al.: Plaintiffs allege unjust enrichment from termination of reinsurance agreements and recapture of assets. A second amended complaint was filed by PGS. Trial is scheduled for April 2026.
• Burnett v. Conseco Life Ins. Co. et al.: Class action lawsuit alleging breach of optional premium payment provisions. A jury returned a notional verdict of approximately $0.2 million for class representatives. A bench trial on alter ego liability was held from August 26 to September 2, 2025, with no ruling yet.
• Regulatory Examinations and Fines: The company is subject to various examinations and inquiries from state, federal, and other authorities regarding sales, underwriting, claims, product design, and other practices.

Stakeholder Impact

• Shareholders: Potential positive impact from increased operating income, dividend increase, and share repurchase program. Negative impact from goodwill impairment and potential uncertainty from legal proceedings. Strategic exit of fee services aims to improve long-term profitability.
• Employees: The exit of the fee services business will impact employees in the Worksite Division, with associated transition costs.
• Policyholders: Financial strength ratings affirmed by major agencies indicate strong capacity to meet obligations. Reinsurance transactions aim to optimize capital and manage risk, indirectly benefiting policyholder security.
• Customers: The strategic focus on core insurance business aims to enhance service and product offerings.
• Creditors: Improved debt to total capital ratio and strong holding company liquidity enhance creditworthiness. Affirmation of credit ratings by agencies provides stability.

Next Steps

• Substantially complete the exit from the fee services business in the first half of 2026.
• Incur $15 million to $20 million of additional pre-tax charges in Q4 2025 related to exit and disposal costs for the fee services business.
• Continue managing to a consolidated RBC ratio of 375% for U.S. based insurance subsidiaries.
• Maintain minimum holding company liquidity of $150 million.
• Manage to a target debt to total capital, excluding accumulated other comprehensive loss, in the range of 25% to 28%.
• Continue the three-year TechMod initiative, with approximately $25 million expected in 2025.
• Post-trial briefing for the Burnett v. Conseco Life Ins. Co. lawsuit is anticipated to be concluded by mid-November.
• Trial for the Platinum Partners Value Arbitrage Fund L.P. lawsuit is scheduled to commence in April 2026.
• Evaluate the effect of ASU 2025-06 (Internal-Use Software) on consolidated financial statements and disclosures.
• Evaluate the effect of ASU 2025-05 (Credit Losses) on consolidated financial statements and disclosures.
• Modify disclosures upon adoption of ASU 2024-03 (Income Statement Expense Disaggregation) and ASU 2023-09 (Income Tax Disclosures).

Key Dates

Recommendation

CNO Financial Group presents a mixed financial picture. While net operating income and operating ROE show positive trends, the significant goodwill impairment and decline in reported net income for the nine-month period are concerning. The strategic decision to exit the unprofitable fee services business is a positive long-term move, expected to enhance future profitability and streamline operations. The company maintains strong capital ratios and liquidity, and its credit ratings have been affirmed with stable outlooks. However, ongoing legal proceedings and the costs associated with the TechMod initiative introduce near-term uncertainties. Given the strategic repositioning and solid core performance offset by one-time charges and legal risks, a 'hold' recommendation is appropriate for investors to observe the successful execution of the strategic exit and the resolution of legal matters before making further investment decisions.

Keywords

CNO Financial Group, SEC Filing, 10-Q, Quarterly Report, Insurance, Annuity, Health Insurance, Life Insurance, Financial Services, Operating Income, Net Income, EPS, Goodwill Impairment, Optavise, Fee Services, Strategic Exit, Reinsurance, Capital Management, Share Repurchase, Dividends, Debt to Capital, Liquidity, Actuarial Review, Market Risk Benefits, Deferred Compensation, Legal Proceedings, Regulatory Compliance, Financial Ratings, TechMod Initiative